• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

ImmuONE

To add a bio or update company history, please click update information.

News from ImmuONE

    ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testingImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
    ImmuONE
    13 Mar 2025

    ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing

    ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.

ImmuONE
  • Life Sciences
  • Milton Keynes, United Kingdom
  • £600k
  • immuone.com
  • Update Information

More venture news

  • Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
    Mironid
    5 Aug 2026

    Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases

    Series BLife Sciences
  • Qureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
    Qureight
    29 Jul 2026

    Qureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease

    Series BLife Sciences
  • Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
    Healome Therapeutics
    7 Jul 2026

    Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn